Health Canada Requires New Warning of Zelboraf Pancreatitis Risk
Wellbeing Canada Requires New Cautioning of Pancreatitis Hazard for Skin-Malignancy Drug Zelboraf. Health Canada is requiring a new warning to be added to the Canadian prescribing information for the skin-cancer drug Zelboraf (vemurafenib) advising of the risk of pancreatitis. Zelboraf is used in adults to treat a type of skin … [Read more...] about Health Canada Requires New Warning of Zelboraf Pancreatitis Risk
Health Canada Requires New Warning of Pancreatitis Risk for Skin-Cancer Drug Zelboraf
Skin-Cancer Drug Zelboraf Pancreatitis Risk. Health Canada is requiring a new warning to be added to the Canadian prescribing information for the skin-cancer. drug Zelboraf (vemurafenib) advising of the risk of pancreatitis Zelboraf is used in adults to treat a type of skin cancer (melanoma with a mutation in a … [Read more...] about Health Canada Requires New Warning of Pancreatitis Risk for Skin-Cancer Drug Zelboraf
Health Canada Warns that Skin-Cancer Drug Zelboraf Carries Risk of Pancreatitis
The skin-cancer drug Zelboraf (vemurafenib) is associated with a risk of pancreatitis, Health Canada warns. According to a safety alert posted on the regulator's website Thursday, the drug's prescribing information has been updated to reflect this risk. Zelboraf is used to treat a specific type of skin cancer in adults that is not … [Read more...] about Health Canada Warns that Skin-Cancer Drug Zelboraf Carries Risk of Pancreatitis
